Shares of Adeptus Health Inc. (NYSE:ADPT) have been given an average recommendation of “Hold” by the ten ratings firms that are presently covering the stock. Three investment analysts have rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $29.50.

Several research analysts have recently commented on the company. KeyCorp set a $31.00 price objective on Adeptus Health and gave the stock a “buy” rating in a research note on Wednesday, November 2nd. Bank of America Corp. downgraded Adeptus Health from a “buy” rating to an “underperform” rating in a research note on Wednesday, November 2nd. Jefferies Group set a $77.00 price objective on Adeptus Health and gave the stock a “buy” rating in a research note on Thursday, September 8th. Goldman Sachs Group Inc. downgraded Adeptus Health from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $72.00 to $12.00 in a research note on Friday, November 4th. Finally, Stephens downgraded Adeptus Health from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, November 2nd.

Shares of Adeptus Health (NYSE:ADPT) opened at 9.71 on Thursday. The company has a 50-day moving average price of $31.07 and a 200-day moving average price of $46.71. The company has a market cap of $159.20 million, a P/E ratio of 1.72 and a beta of 1.22. Adeptus Health has a 52-week low of $7.91 and a 52-week high of $73.44.

Hedge funds have recently added to or reduced their stakes in the company. Municipal Employees Retirement System of Michigan boosted its position in Adeptus Health by 2.4% in the third quarter. Municipal Employees Retirement System of Michigan now owns 2,990 shares of the company’s stock valued at $129,000 after buying an additional 70 shares in the last quarter. Lebenthal Lisanti Capital Growth LLC boosted its position in Adeptus Health by 1.1% in the second quarter. Lebenthal Lisanti Capital Growth LLC now owns 10,790 shares of the company’s stock valued at $557,000 after buying an additional 120 shares in the last quarter. Loomis Sayles & Co. L P boosted its position in Adeptus Health by 0.8% in the first quarter. Loomis Sayles & Co. L P now owns 22,234 shares of the company’s stock valued at $1,235,000 after buying an additional 183 shares in the last quarter. American International Group Inc. boosted its position in Adeptus Health by 2.7% in the third quarter. American International Group Inc. now owns 9,643 shares of the company’s stock valued at $415,000 after buying an additional 252 shares in the last quarter. Finally, Mariner Investment Group LLC boosted its position in Adeptus Health by 1.3% in the second quarter. Mariner Investment Group LLC now owns 39,000 shares of the company’s stock valued at $2,015,000 after buying an additional 500 shares in the last quarter.

Adeptus Health Company Profile

Adeptus Health Inc is a patient-centered healthcare company. The Company is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. The Company has approximately 80 freestanding facilities and over two licensed general hospitals.

5 Day Chart for NYSE:ADPT

Receive News & Stock Ratings for Adeptus Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adeptus Health Inc. and related stocks with our FREE daily email newsletter.